Evidence map›Paper›PMID 28663598›Full record

ReviewActa otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale2017

Cost-effectiveness strategies in OSAS management: a short review.

D M Toraldo, D Passali, A Sanna, F De Nuccio, L Conte, M De Benedetto

Abstract readReview
In one paragraph

Review in Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. A Structured Narrative Review of the OSA-T2DM Axis.Journal of clinical medicine · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Prevalence of Obstructive Sleep Apnea Syndrome: A Single-Center Retrospective Study.International journal of environmental research and public health · 2021
    Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. A review of the "OMICS" for management of patients with obstructive sleep apnoea.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2020
    Review
  14. Article
  15. Assessment of obstructive sleep apnoea (OSA) in children: an update.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2019
    Review
  16. Nasal pathologies in patients with obstructive sleep apnoea.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2019
    Observational
  17. Article
  18. The "Italian way" to counteract obstructive sleep apnoea syndrome in children.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

D M ToraldoHospital Rehabilitation, Dept Cardio-Respiratory Care Unit, "V Fazzi", ASL Lecce, Italy.
D PassaliENT Clinic, University of Siena, Italy.
A SannaPneumology Unit, San Jacopo Hospital, Azienda USL Toscana Centro, Pistoia, Italy.
F De NuccioLaboratory of Human Anatomy and Neuroscience, Dept. of Biological and Environmental Sciences and Technologies, University of Salento, Lecce, Italy.
L ConteLaboratory of Interdisciplinary Research Applied to Medicine (DReAM), University of Salento at the Hospital "V Fazzi", ASL Lecce, Italy.
M De BenedettoENT Unit, "V. Fazzi" Hospital, ASL Lecce, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Obstructive sleep apnoea (OSAS) is an underdiagnosed chronic disease with a high prevalence in adults. It is becoming a significant social problem, since it is associated with a worsening in quality of life and increase in mortality. The cost-effectiveness ratio of diagnostic and therapeutic management of OSAS is a strategic issue to counteract the expected increasing demand of objective testing. OSAS patients with any clinical evidence of comorbidities must be studied using simplified and less expensive systems such as Home Sleep Testing (HST). On the other hand, Sleep Laboratory Polysomnography (PSG) is the gold standard to manage OSAS patients with comorbidities. It should be pointed out that the use of HST can lead to incorrect diagnosis in poorly selected OSAS subjects. This short review discusses various topics for the proper diagnosis and treatment of OSAS in view of epidemiological factors and results in terms of costs and social benefit of the disease. Whatever the strategy chosen and/or the organisational model adopted for managing OSAS, it cannot and should not take into account only cost-effectiveness. Long-term prospective studies evaluating cost-effectiveness ratios and outcomes of OSAS treatment of hospital management models versus home care models are needed.

Indexed as

Cost-Benefit AnalysisHumansModels, TheoreticalPolysomnographySleep Apnea, ObstructiveCost-effectivenessHome sleep testingObstructive sleep apnoea syndromePolysomnographyQuality of LifeTeleservice

Identifiers

PMID28663598
PMCPMC5782420

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.